Sana Biotechnology Inc (SANA)
2.61
+0.26
(+11.06%)
USD |
NASDAQ |
Nov 22, 16:00
2.68
+0.07
(+2.68%)
After-Hours: 20:00
Sana Biotechnology Price: 2.61 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 2.39 | 2.73 | 2.37 | 2.61 | 1.815M |
| Nov 21, 2024 | 2.52 | 2.60 | 2.33 | 2.35 | 1.373M |
| Nov 20, 2024 | 2.42 | 2.54 | 2.33 | 2.53 | 2.063M |
| Nov 19, 2024 | 2.32 | 2.43 | 2.29 | 2.36 | 1.927M |
| Nov 18, 2024 | 2.42 | 2.485 | 2.31 | 2.34 | 2.062M |
| Nov 15, 2024 | 2.63 | 2.65 | 2.345 | 2.42 | 2.638M |
| Nov 14, 2024 | 2.64 | 2.755 | 2.55 | 2.59 | 1.713M |
| Nov 13, 2024 | 2.88 | 3.015 | 2.62 | 2.66 | 1.965M |
| Nov 12, 2024 | 2.87 | 2.87 | 2.745 | 2.84 | 1.884M |
| Nov 11, 2024 | 3.09 | 3.09 | 2.755 | 2.89 | 1.981M |
| Nov 08, 2024 | 3.16 | 3.185 | 3.00 | 3.005 | 1.474M |
| Nov 07, 2024 | 3.42 | 3.45 | 3.03 | 3.10 | 2.716M |
| Nov 06, 2024 | 3.56 | 3.71 | 3.350 | 3.41 | 1.848M |
| Nov 05, 2024 | 3.50 | 3.54 | 2.85 | 3.39 | 3.652M |
| Nov 04, 2024 | 3.66 | 3.81 | 3.53 | 3.76 | 807004.0 |
| Nov 01, 2024 | 3.54 | 3.67 | 3.47 | 3.66 | 1.320M |
| Oct 31, 2024 | 3.66 | 3.70 | 3.50 | 3.50 | 1.086M |
| Oct 30, 2024 | 3.75 | 3.94 | 3.66 | 3.66 | 1.020M |
| Oct 29, 2024 | 3.87 | 3.92 | 3.64 | 3.78 | 942010.0 |
| Oct 28, 2024 | 3.85 | 4.135 | 3.85 | 3.92 | 1.171M |
| Oct 25, 2024 | 3.85 | 3.89 | 3.728 | 3.76 | 701877.0 |
| Oct 24, 2024 | 3.80 | 3.82 | 3.695 | 3.81 | 832339.0 |
| Oct 23, 2024 | 3.93 | 3.96 | 3.69 | 3.79 | 1.062M |
| Oct 22, 2024 | 3.90 | 3.93 | 3.75 | 3.90 | 752582.0 |
| Oct 21, 2024 | 4.21 | 4.21 | 3.895 | 3.93 | 842018.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.34
Minimum
Nov 18 2024
43.50
Maximum
Feb 10 2021
9.969
Average
6.275
Median
Price Benchmarks
| Foghorn Therapeutics Inc | 7.84 |
| Omega Therapeutics Inc | 0.786 |
| Moderna Inc | 41.11 |
| Summit Therapeutics Inc | 19.00 |
| Apellis Pharmaceuticals Inc | 30.77 |
Price Related Metrics
| Price to Book Value | 1.992 |
| Earnings Yield | -53.64% |
| Market Cap | 582.73M |